Objective To develop a method of determining benzene hydrocarbon and halogenated alkane hydrocarbon in the air of workplaces with the capillary gas chromatography of carbon disulphide desorption. Methods Benzene hydrocarbon and halogenated alkane hydrocarbon in the air of workplace were collected by active carbon sampling cuvette, then separated by hydrogen flames detector gas chromatography machine after carbon disulphide desorption. Benzene hydrocarbon and halogenated alkane hydrocarbon were determined quantitively by retention time and quantitatively by apex area. Results The linear ranges of benzene, toluene, p-xylene, m-xylene, o-xylene, ethyl benzene, styenl, chlorobenzene, acetone, carbontetrachloride, dichloromethanl, trichloromethane, 1, 2-dichloroethane, naphth alene were 0.019-81.600, 0.018-91.200, 0.018-88.800, 0.018-56.8, 0.011-92.000, 0.012-63.200, 0.018-93.200, 0.449-2298.400, 0.252-1287.000 and 0.076-390.000 mg/m3 respectively. The recovery rates were 88.4%-98.6% and RSD were 1.0%-6.0%. Conclusion This method can separate efficiently and determine accurately benzene hydrocarbon and halogenated alkane hydrocarbon in the air with a good precision. It is suitable for the determination of the toxicants in the air.

Objective To establish a method to determine halogenated alkane hydrocarbon in drinking water with headspace gas chromatography. Methods Halogenated alkane hydrocarbon in the water were extracted by headspace technology, then analyzed with DB-5 capillary column, in the same time, they were determined with GC by controlling the temperature and the speed of nitrogen. The retention time of the peaks was used for qualitative analysis, while external standard method was used for quantitative analysis. Results The linear ranges for dichloromethane, trichloromethane, 1, 1, 1-trichloroethane, 1, 2-dichloroethane, carbon tetrachloride, trichloroethylene, bromodichloromomethane, 1, 1, 2-trichloroethane, dibromochloromethane, tetrachloroethylene, tribromomethane were 0.8-4 024.0, 0.007-33.5, 0.004-19.2, 1.4-6 821.0, 0.002-10.0, 0.005-25.6, 0.002-12.1, 0.1-717.8, 0.005-23.5, 0.002-8.1 and 0.02-87.7 ?g/L. The lowest determination limit were 0.01- 4.1 ?g/L, the rate of recovery were 89.7%-110.0% and RSDs were 2.8%-9.0%. Conclusion This method can efficiently separate and accurately determine 11 kinds of halogenated alkane hydrocarbon in drinking water. It is simple, rapid and sensitive.

Objective To establish a method for simultaneous determination of kelthane and pyrethroid pesticide residues in water.Methods Kelthane and pyrethroid pesticide residues in the water were extracted by liquid-liquid,then analyzed with DB-1 capillary column.In the same time,they were determined with GC by controlling the temperature.Retention time of the peaks was used for qualitative analysis,while external standard method was used for quantitative analysis.Results The linear ranges of Kelthane,Bifenthrin,Fenpropanate,Lambda cyhalothrin,Permethrin,Beta cyfluthrin,Alphacypermethrin,Fenvalerate were 0.24-31.1,0.21-27.2,0.20-26.0,0.21-26.5,0.20-25.7,0.21-26.4,0.22-29.0 and 0.22-27.4 ?g/L,r≥0.999 0.The lowest determination limits were 0.20,0.33,0.30,0.13,0.36,0.26,0.33 and 0.30 ?g/L,the rate of recovery was 86.0%-111.7% and RSD was 3.8%-11.8%.Conclusion This method can separate efficiently and determine 8 kinds of pyrethroid pesticide residues in the water and only needs 23 minutes.It's simple,rapid and sensitive.

Immune checkpoint inhibitors are members of a class of immune-suppressive molecules that regulate the strength and range of immune responses to avoid normal tissue damage. However, immune checkpoint activity can be stimulated by tumors to es-cape immune surveillance. To elicit anti-tumor effects, immune checkpoint inhibitors can promote the activation of T cells by blocking immune checkpoint proteins. Therefore, these inhibitors can be efficiently and safely used to treat solid tumors. Although the clinical usage of these inhibitors is in the initial stage, they have exhibited good efficacy and safety in lymphoma treatment. This review sum-marizes the biological activities of CTLA-4, PD-1, and PD-L1 and the application of antibodies as drugs for lymphoma treatment.

OBJECTIVE：To investigate the accessibility of antibiotics in essential medicine list in medical institutions of Nanjing area ，and to provide reference for formulating and improving related drug policy. METHODS ：Taking the original and imitated drugs as the objects of investigation ，the standard investigation method jointly formulated by WHO/HAI was adopted to select 35 kinds of antibiotics which were included in Essential Medicine List （2018 edition）and International Drug Price Indicator Guide（2015 edition），and to investigate 3 dimenions such as the availability （proportion of institutions that could provide this drug），price（calculated by MPR ）and affordability （the ratio of drug expenditure to the daily minimum wage of non-technical government workers ）of them in 13 second-class or above medical institutions in Nanjing area by online questionnaires during Jan.-Jun. 2019，so as to put forward the suggestions for drug policy formulation. RESULTS ：The median availability of original drugs was 0，with a range of 0 to 100％；the median availability of generic drugs was 30.80％，with a range of 0 to 100％. The median MPR of original drugs was 5.54，with a range of 1.96 to 18.83；the median MPR of generic drugs was 1.76，with a range of 0.16 to 7.66. Median affordability of original drugs was 8.68，with a range of 1.19 to 41.79；the median affordability of generic drugs was 0.52， with a range of 0.03 to 16.80. CONCLUSIONS：Generic drugs are more available than the originals. The price of original drugs is generally very high ， while the price of generic drugs is mostly cheaper. The affordability of original drugs is really poor ， and the 规。E-mail：shaorong118@163.com affordability of generic drugs is totally good. There are stillrooms for further improvement in the overall accessibility of essential medicines. At present ，ensuring the accessibility of original drugs may be more helpful to meet the needs of treatment. It is suggested to update and adjust the essential medicine list based on the clinical medication requirement ，popularize the knowledge about essential medicines ，properly adjust the price of original drugs and ease the treatment burden of patient. It is supposed to take into full consideration about the regional factors and the needs of different medical institutions when making drug policy.